The history of Viagra and its influence on the pharmaceutical sector presents a challenging question regarding its continued appeal as an investment. Initially a blockbuster success, generating billions , generic competition has significantly eroded financial returns. While leading pharmaceutical firms continue patents on related therapies and inve

The performance of companies tied to iconic drugs like Viagra presents a challenging investment scenario . While the initial boom of copyright, fueled by Viagra's remarkable popularity, generated substantial returns, the loss of exclusivity in key markets has introduced substantial volatility. Investors are now facing the impact of rival medication